Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

167.25 +3.41 (+2.08%)
Official Closing Price Updated: 7:00 PM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,978,527
Open 164.72
Bid (Size) 167.00 (5)
Ask (Size) 167.28 (1)
Prev. Close 163.84
Today's Range 163.63 - 167.31
52wk Range 132.70 - 182.89
Shares Outstanding N/A
Dividend Yield 3.54%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs. 
Via Benzinga
Topics ETFs
MarketBeat Week in Review – 7/1 - 7/5
The market was mostly quiet in a holiday-shortened week; that may change next week with the latest inflation readings and the kickoff of a new earnings season 
Via MarketBeat
Topics Economy
Exposures Interest Rates

Performance

YTD
+4.65%
+4.65%
1 Month
-0.78%
-0.78%
3 Month
-1.50%
-1.50%
6 Month
+3.61%
+3.61%
1 Year
+23.43%
+23.43%

More News

Read More
A Closer Look at AbbVie's Options Market Dynamics
Via Benzinga
AbbVie Stock: A Perfect Dip for Investors to Buy
Via MarketBeat
Topics ETFs
A Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts
Via Benzinga
Looking At AbbVie's Recent Unusual Options Activity
Via Benzinga
Check Out What Whales Are Doing With ABBV
Via Benzinga
New Golden Investment: Universal Health Realty Income Trust
Via Talk Markets
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
Via InvestorPlace
Topics Stocks
Exposures US Equities
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
Via InvestorPlace
3 Retirement All-Stars for Steady Growth and Income
Via InvestorPlace
Topics Retirement
Exposures Pension
Cash Flow Alert: 3 Stocks That Just Raised Their Dividends
Via InvestorPlace
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Via The Motley Fool
3 Magnificent Stocks Retirees Can Buy and Hold Forever
Via The Motley Fool
Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
7 Dividend Kings to Buy With Your Roth IRA Money in 2024
Via InvestorPlace
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
Via Benzinga
Exposures Product Safety
Can AbbVie Stock Keep Outpacing the S&P 500?
Via The Motley Fool
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
AbbVie's Parkinson's Disease Therapy Hits FDA Roadblock
Via Benzinga
Exposures Product Safety
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
Via The Motley Fool
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
Via InvestorPlace
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
Via Talk Markets
Week In Review: FutureGen Sells mAb For IBD To AbbVie In $1.7 Billion Deal
Via Talk Markets
3 Biotech Stocks to Buy Now: June 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.